Oscar Health (OSCR) Cash from Investing Activities (2020 - 2026)

Oscar Health has reported Cash from Investing Activities for 7 years, with the latest figure at -$590.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 238.78% year-over-year to -$590.3 million; the trailing twelve-month figure through Mar 2026 stood at -$657.1 million (up 47.89% YoY), and the FY2025 full-year result was -$241.1 million, up 82.63% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$590.3 million, down from -$48.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $298.8 million in Q3 2022, with the low at -$706.7 million in Q4 2022.
• Historically, Cash from Investing Activities has averaged -$109.9 million across 5 years, with a median of -$31.4 million in 2024.
• The largest YoY upside for Cash from Investing Activities was 2516.48% in 2022 against a maximum downside of 3462.43% in 2022.
• Oscar Health's Cash from Investing Activities stood at -$706.7 million in 2022, then surged by 124.41% to $172.5 million in 2023, then plunged by 118.23% to -$31.4 million in 2024, then slumped by 54.88% to -$48.7 million in 2025, then tumbled by 1111.87% to -$590.3 million in 2026.
• The last three Cash from Investing Activities figures came in at -$590.3 million (Q1 2026), -$48.7 million (Q4 2025), and $150.1 million (Q3 2025), per Business Quant data.